nach oben

01.03.2008 | Original Article | Ausgabe 3/2008

The Relationship Between Alcohol Consumption and Glycemic Control Among Patients with Diabetes: The Kaiser Permanente Northern California Diabetes Registry

Zeitschrift:: Journal of General Internal Medicine > Ausgabe 3/2008

Autoren:: MD, MPH Ameena T. Ahmed, PhD Andrew J. Karter, MPH E. Margaret Warton, MD Jennifer U. Doan, DrPH, MSW Constance M. Weisner

Abstract

BACKGROUND

Alcohol consumption is a common behavior. Little is known about the relationship between alcohol consumption and glycemic control among people with diabetes.

OBJECTIVE

To evaluate the association between alcohol consumption and glycemic control.

DESIGN

Survey follow-up study, 1994–1997, among Kaiser Permanente Northern California members.

PATIENTS

38,564 adult diabetes patients.

MEASUREMENTS

Self-reported alcohol consumption, and hemoglobin A1C (A1C), assessed within 1 year of survey date. Linear regression of A1C by alcohol consumption was performed, adjusted for sociodemographic variables, clinical variables, and diabetes disease severity. Least squares means estimates were derived.

RESULTS

In multivariate-adjusted models, A1C values were 8.88 (lifetime abstainers), 8.79 (former drinkers), 8.90 (<0.1 drink/day), 8.71 (0.1–0.9 drink/day), 8.51 (1–1.9 drinks/day), 8.39 (2–2.9 drinks/day), and 8.47 (≥3 drinks/day). Alcohol consumption was linearly (p < 0.001) and inversely (p = 0.001) associated with A1C among diabetes patients.

CONCLUSIONS

Alcohol consumption is inversely associated with glycemic control among diabetes patients. This supports current clinical guidelines for moderate levels of alcohol consumption among diabetes patients. As glycemic control affects incidence of complications of diabetes, the lower A1C levels associated with moderate alcohol consumption may translate into lower risk for complications.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Jetzt einloggen Kostenlos registrieren

★ PREMIUM-INHALT

e.Med Interdisziplinär

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag als Mediziner*in

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt gratis testen * Jetzt kaufen

Sie können e.Med Interdisziplinär 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Jetzt testen ¹

e.Med Allgemeinmedizin

Kombi-Abonnement

Mit e.Med Allgemeinmedizin erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der allgemeinmedizinischen Zeitschriften, inklusive einer gedruckten Allgemeinmedizin-Zeitschrift Ihrer Wahl.

Jetzt testen ²

Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–9. PubMedCrossRef

Armstrong DG, Lavery LA, van Houtum WH, Harkless LB. The impact of gender on amputation. J Foot Ankle Surg. 1997;36:66–9. PubMed

Morris AD, McAlpine R, Steinke D et al. Diabetes and lower-limb amputations in the community. A retrospective cohort study. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland/Medicines Monitoring Unit. Diabetes Care. 1998;21:738–43. PubMedCrossRef

Most RS, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care. 1983;6:87–91. PubMedCrossRef

Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyorala K. Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland. Diabetes Care. 1993;16:16–20. PubMedCrossRef

Trautner C, Haastert B, Giani G, Berger M. Incidence of lower limb amputations and diabetes. Diabetes Care. 1996;19:1006–9. PubMedCrossRef

USRDS. USRDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. 2001. Bethesda, MD. Tertiary USRDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States.

van Houtum WH, Lavery LA, Harkless LB. The impact of diabetes-related lower-extremity amputations in The Netherlands. J Diabetes Complications. 1996;10:325–30. PubMedCrossRef

Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917–32. PubMedCrossRef

10.

Standards of medical care in diabetes—2006. Diabetes Care. 2006;29 Suppl 1:S4–42.

11.

Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care. 2004;27:17–20. PubMedCrossRef

12.

Substance Abuse and Mental Health Services Administration. Overview of Findings from the 2003 National Survey on Drug Use and Health. 2004. Rockville, MD. Tertiary Overview of Findings from the 2003 National Survey on Drug Use and Health.

13.

Carlsson S, Hammar N, Grill V, Kaprio J. Alcohol consumption and the incidence of type 2 diabetes: a 20-year follow-up of the Finnish twin cohort study. Diabetes Care. 2003;26:2785–90. PubMedCrossRef

14.

Howard AA, Arnsten JH, Gourevitch MN. Effect of alcohol consumption on diabetes mellitus: a systematic review. Ann Intern Med. 2004;140:211–9. PubMed

15.

Lu W, Jablonski KA, Resnick HE et al. Alcohol intake and glycemia in American Indians: the strong heart study. Metabolism. 2003;52:129–35. PubMedCrossRef

16.

Nakanishi N, Suzuki K, Tatara K. Alcohol consumption and risk for development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. Diabetes Care. 2003;26:48–54. PubMedCrossRef

17.

Wannamethee SG, Camargo CA, Jr., Manson JE, Willett WC, Rimm EB. Alcohol drinking patterns and risk of type 2 diabetes mellitus among younger women. Arch Intern Med. 2003;163:1329–36. PubMedCrossRef

18.

Watanabe M, Barzi F, Neal B et al. Alcohol consumption and the risk of diabetes by body mass index levels in a cohort of 5,636 Japanese. Diabetes Res Clin Pract. 2002;57:191–7. PubMedCrossRef

19.

Franz MJ, Bantle JP, Beebe CA et al. Nutrition principles and recommendations in diabetes. Diabetes Care. 2004;27(Suppl 1):S36–46. PubMed

20.

Gordon NP, Kaplan GA. Some evidence refuting the HMO “favorable selection” hypothesis: the case of Kaiser Permanente. Adv Health Econ Health Serv Res. 1991;12:19–39. PubMed

21.

Hiatt RA, Friedman GD. Characteristics of patients referred for treatment of end-stage renal disease in a defined population. Am J Public Health. 1982;72:829–33. PubMedCrossRef

22.

Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82:703–10. PubMedCrossRef

23.

Ferrara A, Karter AJ, Ackerson LM, Liu JY, Selby JV. Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care. 2001;24:1144–50. PubMedCrossRef

24.

Iribarren C, Karter AJ, Go AS et al. Glycemic control and heart failure among adult patients with diabetes. Circulation. 2001;103:2668–73. PubMed

25.

Karter AJ, Rowell SE, Ackerson LM et al. Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care. 1999;22:938–43. PubMedCrossRef

26.

Karter AJ, Ferrara A, Darbinian JA, Ackerson LM, Selby JV. Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care. 2000;23:477–83. PubMedCrossRef

27.

Karter AJ, Ackerson LM, Darbinian JA et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med. 2001;111:1–9. PubMedCrossRef

28.

Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002;287:2519–27. PubMedCrossRef

29.

Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care. 1997;20:1396–402. PubMedCrossRef

30.

Selby JV, Ettinger B, Swain BE, Brown JB. First 20 months’ experience with use of metformin for type 2 diabetes in a large health maintenance organization. Diabetes Care. 1999;22:38–44. PubMedCrossRef

31.

Selby JV, Karter AJ, Ackerson LM, Ferrara A, Liu J. Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes. Diabetes Care. 2001;24:1547–55. PubMedCrossRef

32.

Gual A, Segura L, Contel M, Heather N, Colom J. Audit-3 and audit-4: effectiveness of two short forms of the alcohol use disorders identification test. Alcohol Alcohol. 2002;37:591–6. PubMed

33.

Gronbaek M, Heitmann BL. Validity of self-reported intakes of wine, beer and spirits in population studies. Eur J Clin Nutr. 1996;50:487–90. PubMed

34.

Friesema IH, Veenstra MY, Zwietering PJ, Knottnerus JA, Garretsen HF, Lemmens PH. Measurement of lifetime alcohol intake: utility of a self-administered questionnaire. Am J Epidemiol. 2004;159:809–17. PubMedCrossRef

35.

Harris TR, Wilsnack RW, Klassen AD. Reliability of retrospective self-reports of alcohol consumption among women: data from a U.S. national sample. J Stud Alcohol. 1994;55:309–14. PubMed

36.

Bongers IM, van Oers JA. Mode effects on self-reported alcohol use and problem drinking: mail questionnaires and personal interviewing compared. J Stud Alcohol. 1998;59:280–5. PubMed

37.

Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care. 1988;26:814–23. PubMedCrossRef

38.

Li CL, Tsai ST, Chou P. Persistent impaired glucose tolerance, insulin resistance, and beta-cell dysfunction were independent predictors of type 2 diabetes. J Clin Epidemiol. 2005;58:728–32. PubMedCrossRef

39.

Caballero AE. Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes. Curr Diab Rep. 2004;4:237–46. PubMedCrossRef

40.

Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Heine R, Wareham NJ. Are insulin resistance, impaired fasting glucose and impaired glucose tolerance all equally strongly related to age? Diabet Med. 2005;22:1476–81. PubMedCrossRef

41.

Mackenzie T, Brooks B, O’Connor G. Beverage intake, diabetes, and glucose control of adults in America. Ann Epidemiol. 2006;16:688–91. PubMedCrossRef

42.

Shai I, Wainstein J, Harman-Boehm I et al. Glycemic effects of moderate alcohol intake among patients with type 2 diabetes: A Multi-center, randomized clinical intervention trial. Diabetes Care. 2007.

43.

Avogaro A, Watanabe RM, Gottardo L, de Kreutzenberg S, Tiengo A, Pacini G. Glucose tolerance during moderate alcohol intake: insights on insulin action from glucose/lactate dynamics. J Clin Endocrinol Metab. 2002;87:1233–38. PubMedCrossRef

44.

Facchini F, Chen YD, Reaven GM. Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care. 1994;17:115–9. PubMedCrossRef

45.

Hodge AM, Dowse GK, Collins VR, Zimmet PZ. Abnormal glucose tolerance and alcohol consumption in three populations at high risk of non-insulin-dependent diabetes mellitus. Am J Epidemiol. 1993;137:178–89. PubMed

46.

Kiechl S, Willeit J, Poewe W et al. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). Bmj. 1996;313:1040–44. PubMed

47.

Mayer EJ, Newman B, Quesenberry CP, Jr., Friedman GD, Selby JV. Alcohol consumption and insulin concentrations. Role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation. 1993;88:2190–7. PubMed

48.

Razay G, Heaton KW, Bolton CH, Hughes AO. Alcohol consumption and its relation to cardiovascular risk factors in British women. Bmj. 1992;304:80–3. PubMedCrossRef

49.

Zilkens RR, Puddey IB. Alcohol and cardiovascular disease—more than one paradox to consider. Alcohol and type 2 diabetes—another paradox? J Cardiovasc Risk. 2003;10:25–30. PubMedCrossRef

50.

Meyer KA, Conigrave KM, Chu NF et al. Alcohol consumption patterns and HbA1c, C-peptide and insulin concentrations in men. J Am Coll Nutr. 2003;22:185–94. PubMed

51.

Bell RA, Mayer-Davis EJ, Martin MA, D’Agostino RB, Jr., Haffner SM. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care. 2000;23:1630–36. PubMedCrossRef

52.

Harding AH, Sargeant LA, Khaw KT et al. Cross-sectional association between total level and type of alcohol consumption and glycosylated haemoglobin level: the EPIC-Norfolk Study. Eur J Clin Nutr. 2002;56:882–90. PubMedCrossRef

53.

Kroenke CH, Chu NF, Rifai N et al. A cross-sectional study of alcohol consumption patterns and biologic markers of glycemic control among 459 women. Diabetes Care. 2003;26:1971–8. PubMedCrossRef

54.

Gulliford MC, Ukoumunne OC. Determinants of glycated haemoglobin in the general population: associations with diet, alcohol and cigarette smoking. Eur J Clin Nutr. 2001;55:615–23. PubMedCrossRef

55.

Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Taylor PR. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA. 2002;287:2559–62. PubMedCrossRef

56.

Sierksma A, Patel H, Ouchi N et al. Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care. 2004;27:184–9. PubMedCrossRef

57.

Reijneveld SA, Stronks K. The impact of response bias on estimates of health care utilization in a metropolitan area: the use of administrative data. Int J Epidemiol. 1999;28:1134–40. PubMedCrossRef

58.

Benfante R, Reed D, MacLean C, Kagan A. Response bias in the Honolulu Heart Program. Am J Epidemiol. 1989;130:1088–100. PubMed

59.

Harald K, Salomaa V, Jousilahti P, Koskinen S, Vartiainen E. Non-participation and mortality in different socioeconomic groups: the FINRISK population surveys in 1972–92. J Epidemiol Community Health. 2007;61:449–54. PubMedCrossRef

60.

Van Loon AJ, Tijhuis M, Picavet HS, Surtees PG, Ormel J. Survey non-response in the Netherlands: effects on prevalence estimates and associations. Ann Epidemiol. 2003;13:105–10. PubMedCrossRef

61.

Gordon NP, Kaplan GA. Some evidence refuting the HMO "favorable selection" hypothesis: the case of Kaiser Permanente. Adv Health Econ Health Serv Res. 1991;12:19–39. PubMed

62.

Ahmed AT, Karter AJ, Liu JY. Alcohol consumption is inversely associated with adherence to diabetes self-care behaviors. Diabet Med. 2006;23:795–802. PubMedCrossRef

63.

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:854–65.

64.

Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–12. PubMedCrossRef

Titel: The Relationship Between Alcohol Consumption and Glycemic Control Among Patients with Diabetes: The Kaiser Permanente Northern California Diabetes Registry
Autoren:: MD, MPH Ameena T. Ahmed
PhD Andrew J. Karter
MPH E. Margaret Warton
MD Jennifer U. Doan
DrPH, MSW Constance M. Weisner
Publikationsdatum: 01.03.2008
DOI: https://doi.org/10.1007/s11606-007-0502-z
Verlag: Springer-Verlag
Zeitschrift: Journal of General Internal Medicine
Ausgabe 3/2008
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497

Sie können e.Med Innere Medizin 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.
Sie können e.Med Allgemeinmedizin 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

Neu im Fachgebiet Innere Medizin

21.01.2022 | COVID-19 | Nachrichten

Newsletter bestellen

Bildnachweise

Mail Icon II

Springer Medizin

The Relationship Between Alcohol Consumption and Glycemic Control Among Patients with Diabetes: The Kaiser Permanente Northern California Diabetes Registry

Abstract

BACKGROUND

OBJECTIVE

DESIGN

PATIENTS

MEASUREMENTS

RESULTS

CONCLUSIONS

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

e.Med Innere Medizin

e.Med Allgemeinmedizin

Neu im Fachgebiet Innere Medizin

Nach Vektorimpfstoff ist mRNA-Booster von Vorteil

Nur Subgruppe profitiert von PD-L1-Hemmer gegen Prostata-Ca.

COVID-19 in der Schwangerschaft kann ernste Folgen haben

Drogenkonsum im Lockdown: Wohnzimmer statt Technoparty

Newsletter

Springer Medizin

Abstract

BACKGROUND

OBJECTIVE

DESIGN

PATIENTS

MEASUREMENTS

RESULTS

CONCLUSIONS

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

e.Med Innere Medizin

e.Med Allgemeinmedizin

Weitere Artikel der Ausgabe 3/2008

Prediction of One-Year Survival in High-Risk Patients with Acute Coronary Syndromes: Results from the SYNERGY Trial

Prostate-Specific Antigen Screening and Mortality from Prostate Cancer

Communicating about Alcohol Consumption to Nonharmful Drinkers with Hepatitis C: Patient and Provider Perspectives

Leveraging Primary Care in the Fight Against Lung Cancer

Tips for Teachers of Evidence-Based Medicine: Adjusting for Prognostic Imbalances (Confounding Variables) in Studies on Therapy or Harm

Making Sense of Cancer Risk Calculators on the Web

Neu im Fachgebiet Innere Medizin

Nach Vektorimpfstoff ist mRNA-Booster von Vorteil

Nur Subgruppe profitiert von PD-L1-Hemmer gegen Prostata-Ca.

COVID-19 in der Schwangerschaft kann ernste Folgen haben

Drogenkonsum im Lockdown: Wohnzimmer statt Technoparty

Newsletter